Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

More than 10,000 parents have now taken part in the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) survey led by experts at the University of Oxford.

Sad girl in child psychologist's office

Parents/carers of children aged 4-10 years of age reported that over a one-month period in lockdown, they saw increases in their child’s emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry, according to early results from the Co-SPACE study, asking parents and carers about their children’s mental health through the COVID-19 crisis.

Over a one-month period in lockdown:

  • Parents/carers of primary school age children taking part in the survey report an increase in their child’s emotional, behavioural, and restless/attentional difficulties.
  • Parents/carers of secondary school age children report a reduction in their child’s emotional difficulties, but an increase in restless/attentional behaviours.
  • Adolescents taking part in the survey report no change in their own emotional or behavioural, and restless/attentional difficulties.
  • Parents/carers of children with Special Educational Needs (SEN) and those with a pre-existing mental health difficulty report a reduction in their child’s emotional difficulties and no change in behavioural or restless/attentional difficulties.

Read the full story on the University of Oxford website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.